2019–Present, Professor (tenured), School of Life Sciences (SLS)

2018–Present, Director, Peking University Genome Editing Research Center

2016–Present, Investigator, Beijing Advanced Innovation Center for Genomics (ICG), Peking University

2015–Present, Investigator, Peking-Tsinghua Center for Life Sciences (CLS), Peking University

2014–Present, Investigator, Biomedical Pioneering Innovation Center (BIOPIC), Peking University

2016–Present, Investigator/Associate Professor (tenured), School of Life Sciences (SLS), Peking University

2007–2015, Investigator/Assistant Professor, School of Life Sciences (SLS), Peking University

2005–2007, Research Associate, Department of Genetics, Stanford University School of Medicine

1999–2004, Postdoctoral fellow in Genetics, Stanford University School of Medicine Mentor: Prof. Stanley N. Cohen

1995–1999, Ph.D. in Genetics, Michigan State University, East Lansing, USA

1987–1991, B.S. in Biochemistry, Peking University, China

The research of Wei group  focuses on developing gene editing technologies, novel gene and cell therapies, and high-throughput functional genomics techniques. They aim to investigate the molecular mechanisms of major diseases such as cancer and infections, providing new drug targets and strategies for effective treatments.

2019, BI Investigator Award, 2019

2019, Weiming Outstanding Researcher Award

2018, Beijing Science & Technology Award (Third grade)

2018, China Ministry of Science and Technology Innovation Talent Promotion Plan: Technology Innovation and Entrepreneurship

2018, Peking University Teaching Award

2016, China Patent Award

2016, Tan Jiazhen Life Science Award

2015, Scientific Chinese Man of the Year

2015, Zheng Changxue Teaching Award

2014, Bayer Investigator Award

2014, Roche Chinese Young Investigator Award

2012, Peking University Dongbao Fellowship

2010, Most popular teacher of the School of Life Sciences

1.  Guo W, Tang H, Yi Z, Zhang T, Yuan P, Wang C, Ren S, Chang X, Tang W, Ren J, Sun W, Liu J, Yu Y, Lu Z, Shen H, Yi Z, Zhao Y, Tang G, Han J, Zhang W, Liu H, Sun X, Zhang Y, Zhang C, Wu Y, Yang L, Liu Y, Wang Z, Han F, Xu Y, Qu L, Sun X, Wang J*, Ji W*, Chen Y*, and Wei W* (2026) Long-term reversal of Duchenne muscular dystrophy via circular arRNA-guided exon skipping in monkeys and humans. Cell 189, https://doi.org/10.1016/j.cell.2026.05.030.

2. Song D, Liu G, Zhang W, Ren J, Jin X, Sun Y, Yi Z, Qiu S, Tang H, Yi Z, Wang L, Lu Z, Xie J, Liu H, Tang G, Zhang Y, Yu Y, Yuan P, Liu Y, Xiong W, and Wei W* (2026) RNA structure programs endogenous ADAR for precise and efficient editing. Cell 189, https://doi.org/10.1016/j.cell.2026.04.047.

3. Wu Z, Shi J, Lamao Q, Qiu Y, Yang J, Liu Y, Liang F, Sun X, Tang W, Chen C, Yang Q, Wang C, Li Z, Zhang H, Yang Z, Zhang Y, Yi Y, Zheng X, Sun Y, Ma K, Yu L, Yang H, Wang Z, Zheng W, Yang L, Zhang Z, Zhang Y, Wu Z, Wang Y, Wong CCL, Jin M, Yuan P*, Han W*, and Wei W* (2025) Glycan Shielding Enables TCR-Sufficient Allogeneic CAR-T Therapy. Cell 188, 1-18.

4. Zhang XX, Zhang X, Ren J, Li J, Wei XX, Yu Y, Yi Z*, and Wei W* (2025) Precise modelling of mitochondrial diseases using optimized mitoBEs. Nature 639, 735-745.

5. Yi Z, Zhang X, Tang W, Yu Y, Wei X, Zhang X, and Wei W*. (2023) Strand-Selective Base Editing in Mitochondrial DNA using Programmable Deaminases with Targeted Nickase. Nat Biotechnol 42, 498-509.

6. Qu L, Yi Z, Shen Y, Lin L, Chen F, Xu Y, Wu Z, Tang H, Zhang X, Tian F, Wang C, Xiao X, Dong X, Guo L, Lu S, Yang C, Tang C, Yang Y, Yu W, Wang J, Zhou Y, Huang Q, Yisimayi A, Liu S, Huang W, Cao Y, Wang Y, Zhou Z, Peng X, Wang J-W, Xie X, and Wei W*. (2022) Circular RNA Vaccines against SARS-CoV-2 and Emerging Variants. Cell 185, 1728-1744 e1716.

7. Yi Z, Qu L, Tang H, Liu Z, Liu Y, Tian F, Wang C, Zhang X, Feng Z, Yu Y, Yuan P, Yi Z, Zhao Y, and Wei W*. (2022) Engineered circular ADAR-recruiting RNAs increase the efficiency and fidelity of RNA editing in vitro and in vivo. Nat Biotechnol 40(6): 946-955.

8. Qu L, Yi Z, Zhu S, Wang C, Cao Z, Zhou Z, Yuan P, Yu Y, Tian F, Liu Z, Bao Y, Zhao Y, Wei W*. (2019) Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs. Nat Biotechnol 37, 1059-1069.

9. Zhao X, Zhang G, Chen X, Dai L, Qu X, Li S, Liu S, Song H, Gao Z, Yuan P, Liu Z, Li C, Shang Z, Li Y, Zhang M, Qi J, Wang H, Du N, Wu Y, Bi Y, Gao S, Shi Y, Yan J, Zhang Y, Xie Z*, Wei W* and Gao GF*. (2019) Human Neonatal Fc Receptor Is the Cellular Uncoating Receptor for Enterovirus B. Cell 177(6), 1553-1565.

10. Zhou Y, Zhu S, Cai C, Yuan P, Li C, Huang Y and Wei W*. (2014) High-throughput Screening of a CRISPR/Cas Library for Functional Genomics in Human Cells. Nature 509(7501): 487-91.